Loading
enGene Holdings Inc. Stock: price and insider trades · United States
US·Mcap US$132.7M
No insider purchase over the last 90 days. The latest, by Forbion Growth Opportunities Fund I Cooperatief U.A., was filed 01 Nov 2024.
enGene Holdings Inc.: what insiders have been doing
enGene Holdings Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). No insider at enGene Holdings Inc. has published a filing in the past twelve months. The most recent one dates from 1 November 2024.
In the same market, recent insider purchases at Relmada Therapeutics, Inc. and Uber Technologies, Inc also feature in our signals. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
12
Thresholds
n/a
Buy Volume
€5M
3 ops. · all time
Sell Volume
€64,515
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended October 2025 · cache
US$1.98
Analyst consensus
7 analystsUS$2.00Target US$3.29(+66%)US$5.00
Income statement
EBITDA-US$113.8M
Net income-US$117.3M0.0% margin
Valuation
PER (forward)-1.4x
P/Book0.6x
Beta-0.27
Balance sheet & cash
Market capUS$132.7M
Total debtUS$31.8M
Free Cash Flow-US$100.7M
Debt / Equity14%
Profitability & ownership
ROE-60.5%
ROA-32.0%
% insiders0.1%
% institutions84.1%
Last declaration on 1 November 2024
Declarations12 total
561,797 shares@ US$8.9099.6% of flowCommon SharesSEC:0000950170-24-120079:0
Canonical exit: 28 Jan 2025 (T+90)
2,750 shares@ US$7.16780.4% of flowCommon SharesSEC:0000950170-24-115607:0
Canonical exit: 26 Mar 2024 (T+90)
10,000 shares@ US$5.70100.0% of flowCommon SharesSEC:0000929638-24-003358:0
Canonical exit: 26 Dec 2024 (T+90)
120 shares@ US$0.89100.0% of flowCommon SharesSEC:0000929638-24-002002:0
4,575 shares@ US$15.01100.0% of flowCommon sharesSEC:0000950142-24-001171:0
52,940 shares@ US$0.89100.0% of flowCommon SharesSEC:0000929638-24-001069:0
644,965 shares@ US$10.00100.0% of flowCommon SharesSEC:0000905148-24-000773:0
644,965 shares@ US$10.00100.0% of flowCommon SharesSEC:0000905148-24-000774:0
24,555 sharesCommon SharesSEC:0000929638-23-002987:0
49,933 sharesCommon SharesSEC:0000929638-23-002990:0
1,341,790 sharesCommon SharesSEC:0000929638-23-002986:0
130,085 sharesClass A Common StockSEC:0000950103-23-015956:0
12 of 12 declarations
About enGene Holdings Inc.
enGene Holdings Inc. is a company focused on developing gene therapies. It is listed on NASDAQ under the ticker symbol XNAS.
